Omar Lozano-García

Omar Lozano-García is a Research Professor at Tecnológico de Monterrey, where he serves as the Institute for Obesity Research Leader. His academic work spans bioengineering, medical devices, and nanomedicine, with a strong focus on cardiovascular and obesity-related research. He is actively involved in doctoral education, supervising research proposals and thesis work in the Life Sciences department.

• Doctor of Philosophy in Physics, University of Houston USA
• Master of Physicist Sciences, University of Houston USA
• Industrial Physicist Engineer, Tecnológico de Monterrey

Dr. Lozano-García's research focuses on the intersection of nanotechnology and biomedical applications, particularly in cardiovascular disease and obesity. His work explores nanoparticle toxicology, drug delivery systems, and mitochondrial function in cardiac cells. He investigates how nanomaterials interact with biological systems, with particular attention to cardiotoxicity mechanisms and therapeutic applications for obesity treatment. His research spans from fundamental biophysics to translational applications, with numerous publications in high-impact journals.

Analysis of his recent publications (2023-2025) reveals a strong emphasis on nanomedicine applications for cardiovascular and obesity research. His work consistently explores mitochondrial function in cardiac cells, nanoparticle toxicity mechanisms, and novel drug delivery systems for metabolic diseases. A significant portion of his recent research involves snake venom components for obesity treatment and the cardiotoxic effects of nanoparticles and cancer therapies.

• Nombramiento 'chargé de recherche' conferred by FNRS (2014)
• Mexican Researcher Certification - Level 2

Dr. Lozano-García actively mentors doctoral students through various research stages and thesis development. His research is supported by substantial scientific output, with 36 publications in the last 10 years. His work has gained significant attention, with numerous citations across social media platforms, policy documents, news outlets, and patents. He leads the Bioengineering and Medical Devices strategic research group at Tecnológico de Monterrey, focusing on innovative approaches to obesity and cardiovascular disease.

As leader of the Institute for Obesity Research, Dr. Lozano-García directs a multidisciplinary team investigating novel therapeutic approaches for obesity and related metabolic disorders. His research group combines expertise in nanotechnology, biophysics, and molecular biology to develop innovative solutions for metabolic diseases, with particular emphasis on natural compounds and nanomedicine applications.